Besides, a large increase in diagnostic accuracy of CEA/CA19‐9 was observed in the combination of small eccDNAs originated from some specific genes in plasma, and with potential towards cost‐effective non‐invasive multi‐cancer screening and monitoring. This evidence concerns the gene CEACAM5 and cancer.